Technical Analysis for NURO - NeuroMetrix, Inc.

Grade Last Price % Change Price Change
D 4.15 -0.24% -0.01
NURO closed up 4.0 percent on Wednesday, March 27, 2024, on 5 percent of normal volume.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish -0.24%
180 Bullish Setup Bullish Swing Setup -0.24%
Bollinger Band Squeeze Range Contraction -0.24%
Gapped Up Strength -0.24%
MACD Bearish Signal Line Cross Bearish 3.75%
Bollinger Band Squeeze Range Contraction 3.75%
BB Squeeze Started Range Contraction 3.75%
Gapped Up Strength 3.75%
Shooting Star Candlestick Bearish 1.72%
Lizard Bearish Bearish Day Trade Setup 1.72%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakdown about 3 hours ago
Upper Bollinger Band Resistance about 3 hours ago
60 Minute Opening Range Breakout about 4 hours ago
Up 2% about 4 hours ago
Up 1% about 4 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NeuroMetrix, Inc. Description

NeuroMetrix, Inc., a medical device company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders, such as those associated with carpal tunnel syndrome, lumbosacral disc disease, spinal stenosis, and diabetes. The company focuses on the diagnosis and treatment of neurological complications of diabetes, including diabetic peripheral neuropathy (DPN) and median neuropathy. Its marketed products include NC-stat DPNCheck, a device used to evaluate systemic neuropathies, such as DPN at the point-of-care; SENSUS pain therapy device, a transcutaneous electrical nerve stimulator used for chronic and intractable pain relief; and ADVANCE NCS/EMG system, a platform for the performance of traditional nerve conduction studies and invasive electromyography procedures for the assesment of CTS, low back and leg pain, and DPN, as well as consumables and accessories. The company is also developing SENTINEL device that provides sensory enhancement in the feet targeted at patients who have lost sensory perception in the lower extremities. NeuroMetrix, Inc. distributes its products directly through its direct sales force and independent sales representatives to physicians, clinics, hospitals, managed care organizations, retail health businesses, and independent distributors consisting of primary care, internal medicine, orthopedic and hand surgeons, pain medicine physicians, neurologists, physical medicine and rehabilitation, physicians, and neurosurgeons, as well as endocrinology and podiatry markets primarily in the United States, the United Kingdom, the Netherlands, and India. The company was founded in 1996 and is headquartered in Waltham, Massachusetts.


Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Pain Diabetes Clinic Neuroscience Pain Management Neurophysiology Neuromodulation Managed Care Neurotechnology Primary Care Nervous System Acute Pain Nerve Endocrinology Podiatry Spinal Cord Peripheral Neuropathy Electrodiagnosis Diabetic Peripheral Neuropathy Sensus Carpal Tunnel Carpal Tunnel Syndrome Physical Medicine And Rehabilitation Spinal Cord Disorders Spinal Stenosis Transcutaneous Electrical Nerve Stimulation

Is NURO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 12.04
52 Week Low 2.7
Average Volume 53,270
200-Day Moving Average 4.97
50-Day Moving Average 3.49
20-Day Moving Average 3.95
10-Day Moving Average 3.98
Average True Range 0.24
RSI (14) 61.69
ADX 20.49
+DI 26.64
-DI 15.42
Chandelier Exit (Long, 3 ATRs) 3.71
Chandelier Exit (Short, 3 ATRs) 4.11
Upper Bollinger Bands 4.18
Lower Bollinger Band 3.72
Percent B (%b) 0.95
BandWidth 11.80
MACD Line 0.15
MACD Signal Line 0.15
MACD Histogram 0.0003
Fundamentals Value
Market Cap 4.54 Million
Num Shares 1.09 Million
EPS -5.60
Price-to-Earnings (P/E) Ratio -0.74
Price-to-Sales 0.55
Price-to-Book 0.18
PEG Ratio -0.01
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.42
Resistance 3 (R3) 4.39 4.29 4.37
Resistance 2 (R2) 4.29 4.22 4.30 4.36
Resistance 1 (R1) 4.22 4.18 4.26 4.25 4.34
Pivot Point 4.12 4.12 4.13 4.13 4.12
Support 1 (S1) 4.05 4.05 4.09 4.08 3.98
Support 2 (S2) 3.95 4.01 3.96 3.96
Support 3 (S3) 3.88 3.95 3.95
Support 4 (S4) 3.91